Services Molecular Genetics Genekor is specialized in molecular genetics. Utilizing cutting edge technology, our company offers all the validated molecular tools for the diagnosis, prognosis and individualized treatment of cancer patients. Services Oncology It is generally accepted that cancer is a disease with a genetic background related to acquired or hereditary mutations, gene translocations and over expression of some genes. Mutations take place in genes that are responsible for the smooth operation of the organism with regards to the cellular proliferation, differentiation and cellular death. The majority of cancers is sporadic and is presented in relatively elder people, as they occur from the accumulation of mutations in genes such as K-RAS, EGFR, BRAF, P53 etc. Such mutations are also related to response to targeted therapies. Company Genekor GeneKor is multinational molecular diagnostics company founded in 2007 and operates molecular biology laboratories with state of the art equipment suitable to provide the highest quality of Molecular Services . We provide a diversification of services focused on improving patient care utilizing the latest technologies of prognostic, predictive, and personalized medicine. The clinical expertise of GeneKor focuses on: Response to Targeted Therapy Pharmacogenetics Determination of Hereditary Cancer (Breast Cancer , Colon Cancer , Thyroid Cancer , Pancreatic Cancer , etc.) New Unique Technological Platforms (OncotypeDX BreastTM, OncotypeDX ColonTM, OncotypeDX ProstateTM, PCA3TM) Clinical Utility of Functional RNA Analysis for the Reclassification of Splicing Gene Variants in Hereditary Cancer KONSTANTINOS AGIANNITOPOULOS, GEORGIA PEPE, EIRINI PAPADOPOULOU, GEORGIOS N. TSAOUSIS, STAVROULA KAMPOURI, SONIA MARAVELAKI, ATHANASSIOS FASSAS, CHRISTOS CHRISTODOULOU, RODONIKI IOSIFIDOU, SOFIA KARAGEORGOPOULOU, CHRISTOS MARKOPOULOS, IOANNIS NATSIOPOULOS, KONSTANTINOS PAPAZISIS, MARIA VASILAKI-ANTONATOU, VASSILEIOS VENIZELOS, VAHIT OZMEN, SUALP TANSAN, KERIM KABAN10, DAN TUDOR ENIU, ANGELICA CHIOREAN and GEORGE NASIOULAS Agiannitopoulos et al 2021 Report of a germline double heterozygote in MSH2 and PALB2 Konstantinos Agiannitopoulos, Eirini Papadopoulou, Georgios N. Tsaousis, Georgia Pepe,Stavroula Kampouri, Eleni Patsea, George Lypas Agiannitopoulos et al.2020.pdf About Contact us © 2017 GENEKOR MEDICAL S.A. All rights reserved | Terms of Use | Secure Transactions | Sitemap Committed to biotechnological innovation Change cookies consent Revoke cookies consent